PPHvsSPDW
VanEck Pharmaceutical ETF against SPDR Portfolio Developed World ex-US ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| PPH | SPDW | |
|---|---|---|
| Expense ratio | 0.36% | 0.030% |
| Assets | $1B | $41.1B |
| Net flow, 1 month | +$23M | — |
| Net flow, 1 year | +$303M | +$5B |
| Return, YTD | +4.8% | +12.4% |
| Return, 1 year | +14.7% | +15.7% |
| Avg daily volume | 282K | 2.6M |
| Holdings | 27 | 2480 |
| Listed | Feb 1, 2000 | Apr 20, 2007 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS